Eagle Pharmaceuticals, Inc. to Present at Investor Conferences in June
May 29 2018 - 4:30PM
Business Wire
Eagle Pharmaceuticals, Inc. (“Eagle” or “the Company”) (NASDAQ:
EGRX) announced today that management will present at two investor
conferences in June as follows:
Conference:
Jefferies 2018 Global Healthcare
Conference
Date: Thursday, June 7, 2018 Time: 1:30 p.m. Eastern Daylight Time
Location: Grand Hyatt New York, NYC
Presenters:
Scott Tarriff, Chief Executive Officer,
and Pete Meyers, Chief Financial Officer
Webcast:
http://wsw.com/webcast/jeff113/egrx/
Conference:
William Blair 38th Annual Growth Stock
Conference
Date: Tuesday, June 12, 2018 Time: 3:30 p.m. Central Daylight Time
Location: Four Seasons Hotel, Chicago
Presenters:
David Pernock, President and Chief
Commercial Officer, and Pete Meyers, Chief Financial Officer
Webcast:
http://wsw.com/webcast/blair54/egrx/
The presentations will be webcast live at the aforementioned
times, and archived for 30 days thereafter, via the Company’s
website at www.eagleus.com, under the Investors + News Section.
About Eagle Pharmaceuticals, Inc.
Eagle is a specialty pharmaceutical company focused on
developing and commercializing injectable products that address the
shortcomings, as identified by physicians, pharmacists and other
stakeholders, of existing commercially successful injectable
products. Eagle’s strategy is to utilize the FDA's 505(b)(2)
regulatory pathway. Additional information is available on the
Company’s website at www.eagleus.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20180529006159/en/
Investor Relations for Eagle Pharmaceuticals, Inc:Lisa M.
Wilson, 212-452-2793lwilson@insitecony.com
Eagle Pharmaceuticals (NASDAQ:EGRX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Eagle Pharmaceuticals (NASDAQ:EGRX)
Historical Stock Chart
From Apr 2023 to Apr 2024